Empresa ASLAN Pharmaceuticals Limited Taipei Exchange
Acciones
6497
KYG054241099
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cancer Novel Drugs
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| - | - | 12 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Carl Firth
FOU | Founder | 51 | 01/01/10 |
Kiran Asarpota
DFI | Director of Finance/CFO | 45 | 01/11/10 |
Chief Tech/Sci/R&D Officer | - | 15/03/22 | |
Stephen Doyle
PRN | Corporate Officer/Principal | 50 | 01/02/18 |
Ben Goodger
LAW | General Counsel | 61 | 01/11/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Hoffman
BRD | Director/Board Member | 58 | 30/10/18 |
Andrew Howden
CHM | Chairman | 64 | 01/04/16 |
Carl Firth
FOU | Founder | 51 | 01/01/10 |
Kathleen Metters
BRD | Director/Board Member | 66 | 18/03/21 |
Neil Graham
BRD | Director/Board Member | 65 | 18/02/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 337 297 360 | 333 924 386 ( 99,00 %) | 0 | 99,00 % |
Información de la empresa
Aslan Pharmaceuticals Ltd.
3 Temasek Avenue 18 Level Centennial Tower
039190, Singapore
+
http://www.aslanpharma.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,71 % | 106 mil M | |
+7,02 % | 23,47 mil M | |
-14,68 % | 21,9 mil M | |
-7,05 % | 18,77 mil M | |
-38,55 % | 17,85 mil M | |
-9,52 % | 16,78 mil M | |
+5,18 % | 14,41 mil M | |
+35,72 % | 12,86 mil M | |
+325,79 % | 8778,45 M |